Rockefeller Capital Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99K Sell
873
-19
-2% -$59 ﹤0.01% 4343
2026
Q1
$2.03K Buy
892
+677
+315% +$1.56K ﹤0.01% 4409
2025
Q4
$602 Sell
215
-184
-46% -$658 ﹤0.01% 4510
2025
Q3
$1.92K Buy
+399
New +$2.54K ﹤0.01% 4097
2023
Q1
Sell
-901
Closed -$17K 3279
2022
Q4
$17K Sell
901
-80
-8% -$1.56K ﹤0.01% 2862
2022
Q3
$23K Buy
981
+587
+149% +$18.1K ﹤0.01% 2716
2022
Q2
$12K Buy
394
+362
+1,131% +$13.1K ﹤0.01% 3025
2022
Q1
$1K Sell
32
-1
-3% -$43 ﹤0.01% 3759
2021
Q4
$1K Buy
+33
New +$1.29K ﹤0.01% 3673
2021
Q3
Sell
-35
Closed -$1K 3801
2021
Q2
$1K Sell
35
-22
-39% -$856 ﹤0.01% 3365
2021
Q1
$2K Buy
+57
New +$1.78K ﹤0.01% 3115

Other funds holding ACH

Rockefeller Capital Management's ACH Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Accendra Health (ACH) stake by 2.1% in Q2 2026, selling an estimated $59 and leaving 873 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #4343.

Rockefeller Capital Management first reported a position in ACH in Q1 2021 and has held it in 11 quarters since. The position peaked at $23K in Q3 2022. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Rockefeller Capital Management held 873 shares of Accendra Health worth $2.99K as of Q2 2026.
  • Rockefeller Capital Management sold 19 Accendra Health shares in Q2 2026, an estimated $59.
  • Accendra Health made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4343 holding.
  • Rockefeller Capital Management first reported a position in Accendra Health in Q1 2021 and has held it in 11 quarters since.
  • Rockefeller Capital Management's Accendra Health position peaked at $23K in Q3 2022.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.